Amberstone Biosciences
Laguna Hills, US · Delaware corporation
Founders & leadership
GG
George Guikai WuFounder
YS
Yonglei ShangNamed on SEC filing
WZ
Weian ZhaoNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$6M disclosed across 1 round · 2021
▶$6MraisedDec 2021 · 6 investors · BiotechnologyRule 506(b)
▶$6MraisedDec 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- George Guikai WuExecutive Officer, Director
- Yonglei ShangExecutive Officer, Director
- Weian ZhaoDirector
- Offering amount
- $12M
- Amount sold
- $6M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Amberstone Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase II | 2021 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $300K |
| National Science Foundation | Phase I | 2019 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded Amberstone Biosciences?
- Amberstone Biosciences was founded by George Guikai Wu.
- How much funding has Amberstone Biosciences raised?
- Amberstone Biosciences has disclosed $6M raised across 1 round.
- Where is Amberstone Biosciences headquartered?
- Amberstone Biosciences is headquartered in Laguna Hills, US.
